This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,934.27 firm fixed-price delivery order is for Repatha, a 140 mg/mL injectable medication, with a completion date of November 12, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition. This delivery order is one of many federal contracts held by AmerisourceBergen, demonstrating the company's critical role in supplying essential medical commodities to various government agencies, including the Defense Department and the Department of Justice.
Generated 2/7/25, 9:10 AM